The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement
The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity
Immunological aspects Communicable diseases United States : Protecting our forces : improving vaccine acquisition and availability in the U.S. military / Stanley M. Lemon [and others] editors ; Committee on a strategy for Minimizing the impact of Naturally Occurring Infectious Diseases of Military Importance: Vaccine Issues in the U.S. Military ; Medical Follow-up Agency, Institute of Medicine of the National Academies
Immunological aspects Cytomegaloviruses : Cytomegaloviruses : from molecular pathogenesis to intervention / edited by Matthias J. Reddehase with the assistance of Niels A.W. Lemmermann, Institute of Virology, University Medical Center of the Joahnnes Gutenberg-University, Mainz, Germany
